Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Jan-23 6:33 PM View:  | Fulcrum Therapeutics, Inc. (FULC) | 13-Jan-23 | Market Sale (Planned) | 6,766 | $15.00 | $101,490.00 | (1%) 506.63K to 499.86K | (4%) |
| 08-Jun-22 7:33 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 07-Jun-22 | Option Exercise | 71,435 | $7.84 | $560,050.00 | 14% 506.63K to 578.07K | |
| 08-Jun-22 7:33 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 07-Jun-22 | Planned Option Sale | 71,435 | $8.09 | $577,895.00 | (12%) 578.07K to 506.63K | |
| 06-Jun-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 06-Jun-22 | Option Exercise | 24,382 | $7.84 | $191,155.00 | 5% 506.63K to 531.01K | |
| 06-Jun-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 06-Jun-22 | Planned Option Sale | 24,382 | $8.10 | $197,592.00 | (5%) 531.01K to 506.63K | |
| 06-Jun-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 03-Jun-22 | Option Exercise | 25,551 | $7.84 | $200,320.00 | 5% 506.63K to 532.18K | |
| 06-Jun-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 03-Jun-22 | Planned Option Sale | 25,551 | $7.95 | $203,056.00 | (5%) 532.18K to 506.63K | |
| 06-Jun-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 02-Jun-22 | Option Exercise | 16,689 | $7.84 | $130,842.00 | 3% 506.63K to 523.32K | |
| 06-Jun-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 02-Jun-22 | Planned Option Sale | 16,689 | $7.92 | $132,162.00 | (3%) 523.32K to 506.63K | |
| 11-Apr-22 5:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 07-Apr-22 | Option Exercise | 5,631 | $7.84 | $44,147.00 | 1% 506.63K to 512.26K | |
| 11-Apr-22 5:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 07-Apr-22 | Planned Option Sale | 5,631 | $24.01 | $135,228.00 | (1%) 512.26K to 506.63K | |
| 05-Apr-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 05-Apr-22 | Option Exercise | 52,552 | $7.84 | $412,008.00 | 10% 506.63K to 559.18K | |
| 05-Apr-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 05-Apr-22 | Planned Option Sale | 52,552 | $24.26 | $1,274,770.00 | (9%) 559.18K to 506.63K | |
| 05-Apr-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 04-Apr-22 | Option Exercise | 7,235 | $7.84 | $56,722.40 | 1% 506.63K to 513.87K | |
| 05-Apr-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 04-Apr-22 | Planned Option Sale | 7,235 | $24.02 | $173,749.00 | (1%) 513.87K to 506.63K | |
| 05-Apr-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 01-Apr-22 | Option Exercise | 34,464 | $7.84 | $270,198.00 | 7% 506.63K to 541.09K | |
| 05-Apr-22 7:00 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 01-Apr-22 | Planned Option Sale | 34,464 | $24.03 | $828,160.00 | (6%) 541.09K to 506.63K | |
| 17-Mar-21 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 16-Mar-21 | Market Sale (Planned) | 789 | $12.43 | $9,805.61 | (< 1%) 507.42K to 506.63K | 2% |
| 17-Mar-21 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 15-Mar-21 | Market Sale (Planned) | 9,211 | $12.13 | $111,773.00 | (2%) 516.63K to 507.42K | (< 1%) |
| 18-Feb-21 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 16-Feb-21 | Market Sale (Planned) | 8,215 | $14.27 | $117,197.00 | (2%) 524.85K to 516.63K | (6%) |
| 22-Jan-21 4:30 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 20-Jan-21 | Market Sale (Planned) | 10,000 | $12.08 | $120,826.00 | (2%) 534.85K to 524.85K | (14%) |
| 09-Jul-20 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 08-Jul-20 | Sale (Planned) | 2,500 | $20.00 | $50,000.00 | (< 1%) 537.35K to 534.85K | |
| 26-Jun-20 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 25-Jun-20 | Sale (Planned) | 2,500 | $20.80 | $51,992.00 | (< 1%) 539.85K to 537.35K | |
| 10-Jun-20 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 09-Jun-20 | Sale (Planned) | 156 | $20.00 | $3,120.00 | (< 1%) 540.0K to 539.85K | |
| 09-Jun-20 4:16 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 05-Jun-20 | Sale (Planned) | 3,433 | $20.17 | $69,251.20 | (< 1%) 543.43K to 540.0K | |
| 05-Jun-20 4:26 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 04-Jun-20 | Sale (Planned) | 1,300 | $20.04 | $26,058.00 | (< 1%) 544.73K to 543.43K | |
| 05-Jun-20 4:26 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 03-Jun-20 | Sale (Planned) | 1,500 | $20.13 | $30,192.40 | (< 1%) 546.23K to 544.73K | |
| 03-Jun-20 4:17 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 02-Jun-20 | Sale (Planned) | 2,797 | $20.00 | $55,940.00 | (< 1%) 549.03K to 546.23K | |
| 03-Jun-20 4:17 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 01-Jun-20 | Sale (Planned) | 5 | $20.00 | $100.00 | (< 1%) 549.04K to 549.03K | |
| 01-Jun-20 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 29-May-20 | Sale (Planned) | 1,390 | $20.08 | $27,910.80 | (< 1%) 550.43K to 549.04K | |
| 01-Jun-20 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 28-May-20 | Sale (Planned) | 1,919 | $20.01 | $38,391.10 | (< 1%) 552.35K to 550.43K | |
| 28-May-20 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 26-May-20 | Sale (Planned) | 2,500 | $20.00 | $50,000.00 | (< 1%) 554.85K to 552.35K | |
| 20-Feb-20 4:24 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 19-Feb-20 | Sale (Planned) | 2,500 | $20.00 | $50,000.00 | (< 1%) 557.35K to 554.85K | |
| 31-Dec-15 10:23 AM View: | Epizyme, Inc. (EPZM) | 30-Dec-15 | Option Exercise | 11,805 | $0.51 | $6,020.55 | 100% 0 to 11.8K | |
| 31-Dec-15 10:23 AM View: | Epizyme, Inc. (EPZM) | 30-Dec-15 | Market Option Sale (Planned) | 11,805 | $18.02 | $212,713.00 | (100%) 11.8K to 0 | 40% |
| 31-Dec-15 10:23 AM View: | Epizyme, Inc. (EPZM) | 29-Dec-15 | Option Exercise | 20,303 | $0.51 | $10,354.50 | 100% 0 to 20.3K | |
| 31-Dec-15 10:23 AM View: | Epizyme, Inc. (EPZM) | 29-Dec-15 | Market Option Sale (Planned) | 20,303 | $18.01 | $365,618.00 | (100%) 20.3K to 0 | 39% |
| 10-Sep-15 7:06 PM View: | Epizyme, Inc. (EPZM) | 08-Sep-15 | Option Exercise | 60,000 | $0.51 | $30,600.00 | 100% 0 to 60.0K | |
| 10-Sep-15 7:06 PM View: | Epizyme, Inc. (EPZM) | 08-Sep-15 | Market Option Sale (Planned) | 60,000 | $19.86 | $1,191,740.00 | (100%) 60.0K to 0 | 45% |
| 05-Aug-15 9:38 PM View: | Epizyme, Inc. (EPZM) | 03-Aug-15 | Option Exercise | 60,000 | $0.51 | $30,600.00 | 100% 0 to 60.0K | |
| 05-Aug-15 9:38 PM View: | Epizyme, Inc. (EPZM) | 03-Aug-15 | Market Option Sale (Planned) | 60,000 | $21.97 | $1,318,350.00 | (100%) 60.0K to 0 | 50% |
| 08-Jul-15 4:53 PM View: | Epizyme, Inc. (EPZM) | 06-Jul-15 | Option Exercise | 60,000 | $0.51 | $30,600.00 | 100% 0 to 60.0K | |
| 08-Jul-15 4:53 PM View: | Epizyme, Inc. (EPZM) | 06-Jul-15 | Market Option Sale (Planned) | 60,000 | $23.22 | $1,393,080.00 | (100%) 60.0K to 0 | 53% |
| 04-Nov-14 6:31 PM View: | Epizyme, Inc. (EPZM) | 03-Nov-14 | Option Exercise | 30,000 | $0.51 | $15,300.00 | 100% 0 to 30.0K | |
| 04-Nov-14 6:31 PM View: | Epizyme, Inc. (EPZM) | 03-Nov-14 | Market Option Sale (Planned) | 30,000 | $24.95 | $748,623.00 | (100%) 30.0K to 0 | 56% |
| 03-Oct-14 5:51 PM View: | Epizyme, Inc. (EPZM) | 01-Oct-14 | Option Exercise | 30,000 | $0.51 | $15,300.00 | 100% 0 to 30.0K | |
| 03-Oct-14 5:51 PM View: | Epizyme, Inc. (EPZM) | 01-Oct-14 | Market Option Sale (Planned) | 30,000 | $26.28 | $788,300.00 | (100%) 30.0K to 0 | 59% |
| 04-Sep-14 6:39 PM View: | Epizyme, Inc. (EPZM) | 02-Sep-14 | Option Exercise | 30,000 | $0.51 | $15,300.00 | 100% 0 to 30.0K | |
| 04-Sep-14 6:39 PM View: | Epizyme, Inc. (EPZM) | 02-Sep-14 | Market Option Sale (Planned) | 30,000 | $33.46 | $1,003,900.00 | (100%) 30.0K to 0 | 67% |
| 05-Aug-14 6:26 PM View: | Epizyme, Inc. (EPZM) | 01-Aug-14 | Option Exercise | 30,000 | $0.51 | $15,300.00 | 100% 0 to 30.0K |